Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.
The Scientist
Most Recent
Academics get paid handsome fees to consult with the financial industry, but run the risk of revealing confidential information that leads to illicit gains.
An NIH study finds that the former NFL linebacker who committed suicide last May had signs of degenerative brain disease.
A researcher who studied neurodegenerative diseases made up results from experiments yet to take place in order to apply for more funds.
The neurophysiologist who earned a Nobel Prize for discovering nerve growth factor has passed away at age 103.
Life's Ratchet, The Annotated and Illustrated Double Helix, The Fractalist and Hallucinations
Researchers learn to predict visual imagery in dreams based on functional MRI scans of brain activity during sleep.
A microfluidic device scans individual C. elegans for abnormal traits and sorts wild-type animals from mutants.
Unlike epithelial cells, neurons respond to herpes infection through autophagy, rather than by releasing inflammatory factors.
Founder, Chairman, and CEO, NeuroVigil, Age: 33
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
